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Abstract Emerging evidence points to a role for long non-
coding RNAs in the modulation of epigenetic states and
transcription in human cells. New insights, using various
forms of small non-coding RNAs, suggest that a mechanism
of action is operative in human cells, which utilizes non-
coding RNAs to direct epigenetic marks to homology
containing loci resulting ultimately in the epigenetic-based
modulation of gene transcription. Importantly, insights into
this mechanism of action have allowed for certain target
sequences, which are either actively involved in RNA
mediated epigenetic regulation or targets for non-coding
RNA based epigenetic regulation, to be selected. As such, it
is now feasible to utilize small antisense RNAs to either
epigenetically silence a gene expression or remove epigenetic
silencing of endogenous non-coding RNAs and essentially
turn ona gene expression. Knowledge of thisemerging RNA-
based epigenetic regulatory network and our ability to
cognitively control gene expression has deep implications in
the development of an entirely new area of pharmacopeia.
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Introduction
An enigma in modern-day molecular biology has been
determining what exactly the role is for the massive amount
ofnon-protein-codingtranscriptsfoundinthehumancell.Non-
codingtranscriptshavebeenestimatedtoaccountfor∼70–98%
of the genome (reviewed in (Taft et al. 2007; Morris 2009a)).
These non-coding RNAs (ncRNAs) emanate from non-coding
DNA, regions in the genome that have been dubbed the
“genomic dark matter”; as their functional relevance is
questionable. If the non-coding regions of the human genome
are not thought to be involved in protein coding then what, if
anything, are these non-coding RNAs (ncRNAs) doing? And
why would the cell transcribe vast tracks of DNA to never
produce a protein?
RNA-mediated transcriptional gene silencing
Evidence addressing the central question of what the role is
for ncRNAs in human cells has emerged from studies
carried out with RNA interference (RNAi). RNAi is a
process whereby small double-stranded interfering RNA
(siRNAs) molecules functionally target and direct the
degradation of a homology containing mRNA (reviewed
in (Hannon 2002; Hannon and Rossi 2004)). This form of
RNA-based regulation was termed; post-transcriptional
gene silencing (PTGS). In PTGS, siRNAs are targeted to
messenger RNA, recruiting the native cellular DICER
machinery to degrade the transcript and provide gene
suppression. While PTGS is a potent mechanism for the
targeted degradation of targeted mRNAs, its gene suppres-
sive effect is transient, lasting only until new transcripts are
generated or the siRNAs are degraded. While several
studies have been carried out using RNAi to suppress gene
expression in a PTGS-based manner, one underappreciated
study has created quite a wave of insight. In this study
carried out in human cells, siRNAs were designed to target
a gene promoter instead of the mRNA/coding region. The
result of this siRNA targeting of a gene promoter was the
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upstream of the well-documented PTGS pathway (Morris et
al. 2004). Interestingly, this mode of RNA-based transcrip-
tional suppression appeared to rely on an epigenetic
component, as Trichostatin A and 5′ Aza-cytadine sup-
pressed the obsiRNA-mediated transcriptional gene silencing
(TGS). Notably, the observed siRNA-mediated TGS was
similar to previous work carried out in plants and yeast
(Matzke et al. 2004).
During the course of investigation as to how siRNAs
were capable of directing TGS in human cells, one striking
observation was generated. Weinberg and colleagues (2006)
discovered, quite serendipitously, that only the antisense
strand of the siRNA was required for TGS in human cells.
Other studies have further validated this requirement
(Turner et al. 2009), suggesting that the endogenous
mechanism in human cells whereby ncRNAs regulate gene
transcription may involve forms of RNA beyond double-
stranded RNAs. Later work by several groups have
collectively led to several insights suggesting a model for
how small RNAs can function in controlling gene tran-
scription in human cells (reviewed in (Morris 2009b))
(Fig. 1). In this model, the RNA guides an epigenetic
remodeling complex to the targeted promoter loci which
contains homology to the RNA guide, ultimately resulting
in the epigenetic remodeling of the target site to a
transcriptionally silent state (Fig. 1). While much has been
gleamed from these collective bodies of work, it had
remained unknown whether or not human cells generated
endogenous RNAs that might be regulating gene transcrip-
tion in this manner.
RNAi-mediated suppression of the endogenous non-coding
RNA suppressor results in activation of gene expression
in human cells
Despite earlier observations indicating that small ncRNAs,
derived de novo could affect gene transcription, little was
known as to whether or not there were active ncRNAs
modulating gene transcription in human cells. Some studies
provided evidence that micro-RNAs (miRNAs) could
function as endogenous regulators of gene transcription
(Klase et al. 2007; Omoto and Fujii 2005; Omoto et al.
2004; Tan et al. 2009; Kim et al. 2008). Hints to a deeper
layer of RNA-based transcriptional regulation arose from
one study which set out to target de novo derived siRNAs
to the p21 and E-cadherin promoters, specifically targeting
A:T-rich regions in these promoters. Notably, A:T-rich
regions of the genome are generally found in the coding
bodies of genes, while gene promoters tend to exhibit CpG
islands and palindromic sequences with high GC content,
often times used for transcription factor or protein binding
(Alberts et al. 1994). In this study, it was determined that
these p21 and E-cadherin promoter targeted siRNAs were
able to activate gene expression, though activation of actual
transcription was not demonstrated by nuclear run-on
analysis or RNA polymerase occupancy at the respective
promoters (Li et al. 2006; Place et al. 2008). In these
studies, it was also determined that Argonaute 2 (Ago-2)
was required for the observed activation, suggesting an
RNAi-like effect was responsible for the observed activation
( L ie ta l .2006; Place et al. 2008). This observation is
noteworthy as siRNAs shown to modulate TGS have
generally been observed to require the action of Argonaute
1 (Ago-1), DNA methyltransferase (3a DNMT3a), and
histone deacetylase 1 (HDAC-1) (reviewed in detail in
(Morris 2009a;M o r r i s2009b))(Fig. 1). Nonetheless, the
answer to the question as to how siRNAs targeted to A:T-rich
regions in the p21 and E-cadherin promoters were utilizing
Ago-2 to activate gene expression remained unknown.
During a foray into the mechanism of siRNA-mediated
activation of p21 and E-cadherin, it was determined
mechanistically that the A:T-rich siRNAs were actually
targeting RNAi to an endogenous long antisense ncRNA
(Morris et al. 2008). This observation suggested that
possibly long antisense ncRNAs might be functioning as
endogenous suppressors of p21 and E-cadherin, possibly
regulating their epigenetic states and transcription. Notably,
other tumor suppressor genes also appeared to be under this
newly discovered regulatory mechanism of long antisense
Fig. 1 Small antisense RNA-directed transcriptional gene silencing—a
de novo derived small antisense RNAs, designed to target a promoter of
choice, can interact with promoter-associated RNAs at the transcribed
promoter (Hawkins et al. 2009; Han et al. 2007) and facilitate the
recruitment of epigenetic remodeling complexes (Weinberg et al. 2006;
Turner et al. 2009; Hawkins et al. 2009; Han et al. 2007; Kim et al.
2006;S u z u k ie ta l .2005;S u z u k ie ta l .2008). b The result of small
antisense RNA targeting is the epigenetic remodeling and stable
silencing of transcription from the targeted promoter
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emerge based on several different bodies of work suggest-
ing that long antisense ncRNAs are active regulators of
gene transcription in human cells (Fig. 2). Mechanistically,
this model suggests that the siRNA targeting and degrada-
tion of the gene-specific long antisense ncRNAs affects the
ability of these RNAs to interact with and guide epigenetic
silencing complexes to their particular targeted loci in either
gene bodies or promoters of the sense/mRNA loci for the
gene. The result of this targeting is the activation of gene
expression (Fig. 2)(Morris et al. 2008; Yu et al. 2008;
Camblong et al. 2007; Cho et al. 2005; Ebralidze et al.
2008; Katayama et al. 2005; Knee and Murphy 1997;L ie t
al. 2009; Tufarelli et al. 2003; Wahlestedt 2006).
Fig. 2 Endogenous antisense non-coding RNA mediated transcrip-
tional silencing and activation. Long antisense non-coding RNAs
emanating from either a bidirectionally transcribed, b alternative
alleles, or pseudogenes, (Morris et al. 2008; Hawkins and Morris
2010) can fold into secondary structures (c) and interact with various
proteins as well as target these proteins to homology containing loci in
the genome (d). The antisense RNA protein complexes can then target
the corresponding homology containing loci in the genome where
epigenetic remodeling of the local chromatin via directed histone and
DNA methylation can occur (e). When the antisense non-coding
RNAs are targeted by either single-stranded oligonucleotides or
siRNAs, the secondary structure is changed or interactions with the
epigenetic remodeling protein complexes are blocked (f). The result is
a loss of antisense non-coding RNA-directed epigenetic regulation of
gene expression and subsequent activation of gene transcription (g)
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epigenetically regulate gene expression. In a recent study,
an Oct-4 regulatory long-antisense ncRNA emanating from
Oct-4 pseudogene 5 (Hawkins and Morris 2010) was found
to be involved in epigenetically regulating Oct-4. Notably,
this particular antisense ncRNA is not poly-adenylated,
contains Oct-4 intronic sequences, and was found to
specifically overlap segments of the Oct-4 promoter. The
suppression of this Oct-4 antisense ncRNA resulted in a
loss of H3K27 and H3K9 methylation at the Oct-4
promoter and activation of Oct-4 transcription (Hawkins
and Morris 2010). The suppression of Ezh2 and G9a also
had an impact on Oct-4 transcription; the loss of these factors
resulted in increased transcription of Oct-4, suggesting that
Oct-4 might be under epigenetic regulation via the action of
this Oct-4 targeted long antisense ncRNA emanating from
Oct-4 pseudogene 5 (Hawkins and Morris 2010).
Taken together, these data, along with those from studies
carriedoutonp21andp15(Morrisetal.2008;Y ue ta l .2008;
Hawkins and Morris 2010), indicated that siRNA-directed
gene activation is in essence “RNAi-mediated suppression of
the endogenous ncRNA epigenetic suppressor”,w h i c h
results in a loss of endogenous epigenetic brakes being
instilled in the particular gene by the action of the long
antisense ncRNA (Fig. 2 and reviewed in (Morris 2009a;
Morris 2009b)). Others have also found ncRNAs acting in
the modulation of epigenetic states of imprinted genes (Tsai
et al. 2010). These new findings strongly implicate long
antisense ncRNAs as epigenetic regulators of gene expres-
sion in human cells. Such observations offer significant
insights into a major question in biology: How do epigenetic
changes get instilled at particular loci?
While the insights gained from these bodies of work
indicate that a vastly more complex regulatory network is
operative in human cells they also suggest that some form
of regulation can be instilled in a gene-specific manner, i.e.,
we can turn a gene on or off transcriptionally. Evidence
with small RNA-targeted TGS has demonstrated that stable
long-term silencing can be established after a relatively
short duration of small RNA targeting to a gene promoter
(Turner et al. 2009; Hawkins et al. 2009). This form of
long-term silencing required Histone Deacetylase 1
(HDAC1), DNA methyltransferase 3A (DNMT3a), and
epigenetic changes such as histone 3 lysine 9 di-methylation
as well as histone 3 lysine 27 tri-methylation at the targeted
site for the initiation of silencing. Conversely, the long-term
maintenance of silencing required the action of DNA
methyltransferase 1 (DNMT1) and DNMT3a as well as
DNA methylation at the targeted promoter (Turner et al.
2009; Hawkins et al. 2009). The impact of a set of molecules
that can govern this form of control cannot be overstated as
long-lasting effects can, by extension, have an impact on the
evolution of the cell. Interestingly, to date, the majority of
genes exhibiting long antisense ncRNAs appear to be tumor
suppressors (reviewed (Morris and Vogt 2010)). These
observations might speak to a role for dysregulated long
antisense ncRNA-based networks in the evolution of
epigenetic silencing and cancer (Morris and Vogt 2010)?
Conclusion
The observations that antisense ncRNAs are involved in
regulating gene expression in differentiated cells (reviewed
in (Morris 2009b)) adds to the growing complexity of
known long ncRNAs involved in cellular regulation.
Examples include the Xist antisense ncRNA TSIX, which
is involved in dosage compensation and X-inactivation in
undifferentiated primordial cells (reviewed (Lee 2009)).
Other examples of ncRNAs involved in epigenetic regula-
tion can be found in the imprinted genes (reviewed in
(LatosandBarlow2009)). These long ncRNAs also appear to
function by targeting the recruitment of different epigenetic
regulatory complexes to their intended targets. Clearly, the
emerging evidence suggests that in human cells many more
genes than previously envisioned, beyond X-inactivation and
imprinted genes might actually be regulated by long ncRNAs.
In fact, ncRNAs might be actively switching on and off genes
in an orchestral regulation that governs the fidelity of the cell
and functions in cellular adaption. Knowledge of this
mechanism can no doubt prove useful in future therapeutics
aimed at controlling gene expression in a transcriptional
manner. Future therapies may utilize small RNAs or various
chemically modified oligonucleotides to epigenetically mod-
ulate a gene transcription or to target endogenous ncRNAs
actively involved in regulating particular genes expression.
While we may be clearly on the verge of a new therapeutic
platform that allows for the targeted control of gene
transcription via controlled epigenetic targeting, one issue
will continue to remain: delivery.
Acknowledgments This project is funded by NIH R01 HL083473
and NIH R01 AI084406 to KVM.
References
Alberts BBD, Lewis J, Raff M, Roberts K, Watson JD (1994) Molecular
biology of the cell, 3rd edn. Garland Publishing, New York
Camblong J, Iglesias N, Fickentscher C, Dieppois G, Stutz F (2007)
Antisense RNA stabilization induces transcriptional gene silencing
via histone deacetylation in S. cerevisiae. Cell 131:706–717
ChoDH,ThienesCP,MahoneySE,AnalauE,FilippovaGN,TapscottSJ
(2005) Antisense transcription and heterochromatin at the DM1
CTG repeats are constrained by CTCF. Mol Cell 20:483–489
Ebralidze AK, Guibal FC, Steidl U, Zhang P, Lee S, Bartholdy B,
Jorda MA, Petkova V, Rosenbauer F, Huang G, Dayaram T,
Klupp J, O’Brien KB, Will B, Hoogenkamp M, Borden KL,
436 Clin Epigenet (2011) 2:433–437Bonifer C, Tenen DG (2008) PU.1 expression is modulated by
the balance of functional sense and antisense RNAs regulated by
a shared cis-regulatory element. Genes Dev 22:2085–2092
Han J, Kim D, Morris KV (2007) Promoter-associated RNA is
required for RNA-directed transcriptional gene silencing in
human cells. Proc Natl Acad Sci U S A 104:12422–12427
Hannon GJ (2002) RNA interference. Nature 418:244–251
Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human
genome with RNA interference. Nature 431:371–378
Hawkins PG, Morris KV (2010) Transcriptional regulation of Oct4 by
a long non-coding RNA antisense to Oct4-pseudogene 5.
Transcription 1:165–175
Hawkins PG, Santoso S, Adams C, Anest V, Morris KV (2009)
Promoter targeted small RNAs induce long-term. Nucleic Acids
Res 37:2984–2995
Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M,
Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, Suzuki
H, Carninci P, Hayashizaki Y, Wells C, Frith M, Ravasi T, Pang
KC, Hallinan J, Mattick J, Hume DA, Lipovich L, Batalov S,
Engstrom PG, Mizuno Y, Faghihi MA, Sandelin A, Chalk AM,
Mottagui-Tabar S, Liang Z, Lenhard B, Wahlestedt C (2005)
Antisense transcription in the mammalian transcriptome. Science
309:1564–1566
Kim DH, Villeneuve LM, Morris KV, Rossi JJ (2006) Argonaute-1
directs siRNA-mediated transcriptional gene silencing in human
cells. Nat Struct Mol Biol 13:793–797
Kim DH, Saetrom P, Snove O Jr, Rossi JJ (2008) MicroRNA-directed
transcriptional gene silencing in mammalian cells. Proc Natl
Acad Sci U S A 105:16230–16235
Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R,
McCaffrey T, Kashanchi F (2007) HIV-1 TAR element is
processed by Dicer to yield a viral micro-RNA involved in
chromatin remodeling of the viral LTR. BMC Mol Biol 8:63
Knee R, Murphy PR (1997) Regulation of gene expression by natural
antisense RNA transcripts. Neurochem Int 31:379–392
Latos PA, Barlow DP (2009) Regulation of imprinted expression by
macro non-coding RNAs. RNA Biol 6:100–106
Lee JT (2009) Lessons from X-chromosome inactivation: Long
ncRNA as guides and tethers to the epigenome. Genes Dev
23:1831–1842
Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida
H, Dahiya R (2006) Small dsRNAs induce transcriptional
activation in human cells. Proc Natl Acad Sci U S A
103:17337–17342
Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ,
Samant GV, Zhao B, Garnaas MK, Horswill MA, Stanhope SA,
North PE, Miao RQ, Wilkinson GA, Affolter M, Ramchandran R
(2009) A noncoding antisense RNA in tie-1 locus regulates tie-1
function in vivo. Blood 115:133–139
Matzke M, Aufsatz W, Kanno T, Daxinger L, Papp I, Mette MF,
Matzke AJ (2004) Genetic analysis of RNA-mediated transcrip-
tional gene silencing. Biochim Biophys Acta 1677:129–141
Morris KV (2009a) Non-coding RNAs, epigenetic memory, and the
passage of information to progeny. RNA Biol 6:242–247
Morris KV (2009b) Long antisense non-coding RNAs function to
direct epigenetic complexes. Epigenetics 4:296–301
Morris KV, Vogt PK (2010) Long antisense non-coding RNAs and
their role in transcription and oncogenesis. Cell Cycle 9:2542–
2545
Morris KV, Chan SW, Jacobsen SE, Looney DJ (2004) Small
interfering RNA-induced transcriptional gene silencing in human
cells. Science 305:1289–1292
Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG (2008)
Bidirectional transcription directs both transcriptional gene
activation and suppression in human cells. PLoS Genet 4:
e1000258
Omoto S, Fujii YR (2005) Regulation of human immunodeficiency
virus 1 transcription by nef microRNA. J Gen Virol 86:751–755
Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H, Brisibe EA,
Saksena NK, Fujii YR (2004) HIV-1 nef suppression by virally
encoded microRNA. Retrovirology 1:44
Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-
373 induces expression of genes with complementary promoter
sequences. Proc Natl Acad Sci U S A 105:1608–1613
Suzuki K, Shijuuku T, Fukamachi T, Zaunders J, Guillemin G, Cooper
D, Kelleher A (2005) Prolonged transcriptional silencing and
CpG methylation induced by siRNAs targeted to the HIV-1
promoter region. Journal of RNAi and Gene Silencing 1:66–78
Suzuki K, Juelich T, Lim H, Ishida T, Watanebe T, Cooper DA, Rao S,
Kelleher AD (2008) Closed chromatin architecture is induced by
an RNA duplex targeting the HIV-1 promoter region. J Biol
Chem 283:23353–23363
Taft RJ, Pheasant M, Mattick JS (2007) The relationship between non-
protein-coding DNA and eukaryotic complexity. BioEssays
29:288–299
Tan Y, Zhang B, Wu T, Skogerbo G, Zhu X, Guo X, He S, Chen R
(2009) Transcriptional inhibiton of Hoxd4 expression by
miRNA-10a in human breast cancer cells. BMC Mol Biol 10:12
Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi
Y, Segal E, Chang HY (2010) Long noncoding RNA as modular
scaffold of histone modification complexes. Science 329:689–
693
Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG,
Higgs DR (2003) Transcription of antisense RNA leading to gene
silencing and methylation as a novel cause of human genetic
disease. Nat Genet 34:157–165
Turner AM, De La Cruz J, Morris KV (2009) Mobilization-competent
lentiviral vector-mediated sustained transcriptional modulation of
HIV-1 expression. Mol Ther 17:360–368
Wahlestedt C (2006) Natural antisense and noncoding RNA tran-
scripts as potential drug targets. Drug Discov Today 11:503–508
Weinberg MS, Villeneuve LM, Ehsani A, Amarzguioui M, Aagaard L,
Chen ZX, Riggs AD, Rossi JJ, Morris KV (2006) The antisense
strand of small interfering RNAs directs histone methylation and
transcriptional gene silencing in human cells. RNA 12:256–262
Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP,
Cui H (2008) Epigenetic silencing of tumour suppressor gene
p15 by its antisense RNA. Nature 451:202–206
Clin Epigenet (2011) 2:433–437 437